Treace Medical Concepts (TMCI) Non Operating Interest Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Non Operating Interest Expenses for 7 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 18.24% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (up 10.67% YoY), and the FY2025 full-year result was $5.3 million, up 1.22% from the prior year.
• Non Operating Interest Expenses declined to $1.6 million in Q2 2026 per TMCI's latest filing, from $1.6 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.6 million in Q1 2026 and bottomed at $946000.0 in Q2 2022.
• Historically, Non Operating Interest Expenses has averaged $1.3 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses slipped 8.86% in 2022, then surged 35.52% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $1.3 million in 2022, then retreated by 0.53% to $1.3 million in 2023, then gained by 0.77% to $1.3 million in 2024, then grew by 2.74% to $1.3 million in 2025, then gained by 15.7% to $1.6 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $1.6 million, $1.6 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.